AMANTADINE

AMANTADINE was reported 13067 times

AMANTADINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSKINESIA HYPERPYREXIA SYNDROME 29 0.6170
1 PARKINSONISM HYPERPYREXIA SYNDROME 43 0.2402
2 DOPAMINE DYSREGULATION SYNDROME 47 0.1054
3 DEEP BRAIN STIMULATION 61 0.1010
4 FREEZING PHENOMENON 286 0.0772
5 DELUSION OF PARASITOSIS 12 0.0764
6 STOMA SITE INDURATION 9 0.0756
7 CATHETER SITE NODULE 12 0.0628
8 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 25 0.0622
9 ON AND OFF PHENOMENON 343 0.0617
10 SPINAL CORD HAEMATOMA 13 0.0607
11 STOMA SITE ODOUR 13 0.0580
12 PARKINSONIAN REST TREMOR 9 0.0476
13 STOMA SITE INFECTION 59 0.0453
14 STOMA SITE ERYTHEMA 84 0.0449
15 SOMATIC DELUSION 11 0.0447
16 STOMA SITE HYPERGRANULATION 28 0.0444
17 STOMA SITE OEDEMA 9 0.0411
18 STOMA SITE PAIN 59 0.0401
19 SALIVA DISCOLOURATION 13 0.0389
20 STOMA SITE DISCHARGE 106 0.0387
21 HYPERKINESIA 82 0.0386
22 STOMA SITE REACTION 24 0.0350
23 DEVICE COLOUR ISSUE 14 0.0347
24 DUPLICATE THERAPY ERROR 11 0.0343
25 STOMA SITE EXTRAVASATION 13 0.0337
26 REDUCED FACIAL EXPRESSION 34 0.0335
27 CATHETER SITE BRUISE 11 0.0332
28 IMPULSE-CONTROL DISORDER 66 0.0320
29 JEALOUS DELUSION 9 0.0318
30 PARKINSONIAN GAIT 19 0.0304
31 DYSKINESIA 1114 0.0274
32 MORPHOEA 13 0.0269
33 RESTING TREMOR 17 0.0263
34 GAIT SPASTIC 9 0.0262
35 STOMA COMPLICATION 25 0.0246
36 LIVEDO RETICULARIS 51 0.0244
37 SEXUALLY INAPPROPRIATE BEHAVIOUR 11 0.0236
38 BASAL GANGLIA INFARCTION 8 0.0233
39 BRADYKINESIA 136 0.0230
40 INFUSION SITE NODULE 22 0.0229
41 STOMA SITE INFLAMMATION 17 0.0228
42 COMPULSIONS 15 0.0225
43 SLEEP TALKING 38 0.0224
44 STOMA SITE HAEMORRHAGE 34 0.0221
45 STOMA SITE IRRITATION 12 0.0221
46 HYPERSEXUALITY 40 0.0219
47 HALLUCINATION, VISUAL 461 0.0218
48 SOFT TISSUE MASS 10 0.0216
49 CEREBRAL HYPOPERFUSION 10 0.0215
50 INFUSION SITE CELLULITIS 11 0.0208
51 AKINESIA 43 0.0207
52 ILLUSION 30 0.0181
53 HALLUCINATION 1356 0.0180
54 CORNEAL OEDEMA 40 0.0178
55 HALLUCINATIONS, MIXED 74 0.0176
56 THERAPEUTIC PRODUCT EFFECT VARIABLE 67 0.0173
57 COGWHEEL RIGIDITY 18 0.0171
58 MALE SEXUAL DYSFUNCTION 10 0.0167
59 RELAPSING-REMITTING MULTIPLE SCLEROSIS 14 0.0162
60 YAWNING 42 0.0157
61 MUSCLE RIGIDITY 188 0.0157
62 DEMENTIA WITH LEWY BODIES 17 0.0153
63 DRUG EFFECT VARIABLE 17 0.0150
64 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 15 0.0149
65 DEVICE ALARM ISSUE 27 0.0149
66 CATHETER SITE RELATED REACTION 11 0.0147
67 ACUTE PSYCHOSIS 36 0.0145
68 MONOCYTE PERCENTAGE INCREASED 10 0.0141
69 COMPULSIVE SHOPPING 29 0.0141
70 REHABILITATION THERAPY 52 0.0134
71 PSYCHOTIC SYMPTOM 27 0.0131
72 POSTURE ABNORMAL 42 0.0129
73 URINE LEUKOCYTE ESTERASE POSITIVE 9 0.0129
74 STEREOTYPY 12 0.0127
75 HYPORESPONSIVE TO STIMULI 14 0.0119
76 DELUSION 184 0.0118
77 DYSTONIA 229 0.0118
78 NEUROLEPTIC MALIGNANT SYNDROME 138 0.0116
79 DEVICE LOOSENING 10 0.0116
80 PRODUCT RESIDUE PRESENT 62 0.0115
81 BLADDER CATHETERISATION 11 0.0114
82 GAZE PALSY 19 0.0111
83 ALTERED VISUAL DEPTH PERCEPTION 9 0.0110
84 AUTONOMIC NERVOUS SYSTEM IMBALANCE 32 0.0109
85 NONSPECIFIC REACTION 58 0.0106
86 PROGRESSIVE MULTIPLE SCLEROSIS 12 0.0104
87 MUTISM 15 0.0103
88 DEVICE CONNECTION ISSUE 20 0.0095
89 NEUROGENIC BLADDER 20 0.0095
90 FRACTURED COCCYX 12 0.0095
91 PERONEAL NERVE PALSY 53 0.0093
92 DISORGANISED SPEECH 17 0.0092
93 HYPERAMMONAEMIC ENCEPHALOPATHY 16 0.0092
94 PATHOLOGICAL GAMBLING 15 0.0090
95 FINE MOTOR SKILL DYSFUNCTION 26 0.0090
96 CATHETER SITE DISCHARGE 10 0.0089
97 PERSECUTORY DELUSION 22 0.0088
98 WHITE MATTER LESION 11 0.0087
99 LUMBAR RADICULOPATHY 10 0.0086
100 DEVICE OCCLUSION 120 0.0085
101 DEVICE KINK 31 0.0085
102 GAMBLING DISORDER 22 0.0081
103 B-LYMPHOCYTE COUNT DECREASED 11 0.0081
104 DISINHIBITION 13 0.0081
105 LIVING IN RESIDENTIAL INSTITUTION 15 0.0080
106 CATHETER SITE ERYTHEMA 17 0.0079
107 DIZZINESS POSTURAL 77 0.0079
108 INTENTIONAL UNDERDOSE 58 0.0079
109 PARKINSONISM 77 0.0079
110 WHEELCHAIR USER 35 0.0079
111 DROOLING 54 0.0078
112 INFUSION SITE IRRITATION 10 0.0078
113 JC POLYOMAVIRUS TEST POSITIVE 9 0.0077
114 ANTICHOLINERGIC SYNDROME 12 0.0075
115 MUSCLE SPASTICITY 91 0.0074
116 BALANCE DISORDER 639 0.0074
117 HOSPICE CARE 72 0.0073
118 NASAL DISCHARGE DISCOLOURATION 10 0.0072
119 ORTHOSTATIC HYPOTENSION 124 0.0071
120 SEIZURE LIKE PHENOMENA 12 0.0071
121 MOTOR DYSFUNCTION 71 0.0070
122 INFUSION SITE BRUISING 15 0.0069
123 CATHETER SITE PAIN 18 0.0069
124 IMPULSIVE BEHAVIOUR 26 0.0069
125 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 13 0.0069
126 CEREBRAL ATROPHY 27 0.0068
127 INFUSION SITE INDURATION 10 0.0067
128 PSYCHOTIC DISORDER 192 0.0065
129 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 17 0.0065
130 GASTROSTOMY 10 0.0064
131 JOINT INSTABILITY 9 0.0064
132 SEROTONIN SYNDROME 123 0.0064
133 MYOCLONUS 76 0.0064
134 TONGUE BITING 13 0.0063
135 URINARY HESITATION 15 0.0063
136 SLOW SPEECH 15 0.0062
137 DYSPHEMIA 27 0.0062
138 WALKING AID USER 40 0.0061
139 ABNORMAL SLEEP-RELATED EVENT 8 0.0061
140 INFUSION SITE INFECTION 14 0.0060
141 METABOLIC ENCEPHALOPATHY 18 0.0060
142 THERAPEUTIC RESPONSE SHORTENED 197 0.0059
143 PALLIATIVE CARE 9 0.0059
144 HYPOKINESIA 83 0.0057
145 CATATONIA 30 0.0057
146 PARANOIA 97 0.0056
147 GASTROINTESTINAL TUBE INSERTION 14 0.0056
148 MULTIPLE SCLEROSIS RELAPSE 381 0.0056
149 ABNORMAL DREAMS 153 0.0055
150 IMMOBILE 24 0.0055
151 FALL 1821 0.0055
152 SPEECH DISORDER 285 0.0054
153 CHOKING 105 0.0054
154 URINE ANALYSIS ABNORMAL 16 0.0053
155 PRE-EXISTING CONDITION IMPROVED 33 0.0053
156 TORTICOLLIS 11 0.0052
157 GAIT INABILITY 172 0.0051
158 DEVICE POWER SOURCE ISSUE 15 0.0051
159 PSYCHIATRIC DECOMPENSATION 10 0.0051
160 DECUBITUS ULCER 41 0.0050
161 INFUSION SITE REACTION 15 0.0050
162 HYPERNATRAEMIA 25 0.0050
163 MOBILITY DECREASED 360 0.0050
164 BEHAVIOUR DISORDER 27 0.0050
165 STARING 12 0.0050
166 INCOHERENT 32 0.0049
167 TREMOR 819 0.0049
168 PNEUMOPERITONEUM 9 0.0049
169 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 16 0.0048
170 GAIT DISTURBANCE 922 0.0048
171 WHITE BLOOD CELLS URINE POSITIVE 9 0.0048
172 SKIN LACERATION 52 0.0048
173 POTENTIATING DRUG INTERACTION 16 0.0048
174 CLUMSINESS 13 0.0048
175 DYSSTASIA 139 0.0048
176 STRIDOR 14 0.0048
177 DELIRIUM 165 0.0047
178 DECREASED INTEREST 28 0.0047
179 EYE CONTUSION 10 0.0047
180 HYPERSOMNIA 133 0.0046
181 HALLUCINATION, AUDITORY 73 0.0046
182 HYPERTHERMIA 35 0.0046
183 HEAD INJURY 145 0.0046
184 MULTIPLE SCLEROSIS 219 0.0046
185 MOVEMENT DISORDER 147 0.0046
186 DYSGRAPHIA 30 0.0045
187 CATHETER SITE INFECTION 17 0.0045
188 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 10 0.0045
189 GENERALISED TONIC-CLONIC SEIZURE 74 0.0045
190 MICTURITION URGENCY 51 0.0045
191 DEVICE USE ISSUE 78 0.0045
192 MIDDLE INSOMNIA 83 0.0044
193 UROSEPSIS 41 0.0044
194 SKIN ABRASION 21 0.0044
195 DEMENTIA 123 0.0044
196 FAECALOMA 24 0.0044
197 NOCTURIA 53 0.0044
198 PNEUMONIA ASPIRATION 108 0.0043
199 OBSESSIVE-COMPULSIVE DISORDER 34 0.0042
200 BLADDER DISORDER 42 0.0042
201 LOSS OF CONTROL OF LEGS 16 0.0042
202 VOLVULUS 10 0.0042
203 DRY MOUTH 335 0.0041
204 ATROPHY 8 0.0041
205 PROSTATOMEGALY 16 0.0041
206 COGNITIVE DISORDER 190 0.0041
207 INCONTINENCE 43 0.0041
208 SLEEP TERROR 17 0.0040
209 CONFUSIONAL STATE 650 0.0040
210 SPUTUM DISCOLOURED 38 0.0040
211 CATHETER SITE HAEMORRHAGE 10 0.0040
212 LOGORRHOEA 14 0.0040
213 INFUSION SITE HAEMORRHAGE 13 0.0039
214 RIB FRACTURE 81 0.0039
215 ASPIRATION 43 0.0039
216 SEDATION COMPLICATION 10 0.0039
217 INFUSION SITE ERYTHEMA 33 0.0039
218 PRESCRIBED UNDERDOSE 78 0.0039
219 NIGHTMARE 135 0.0039
220 ANAL INCONTINENCE 35 0.0039
221 MUSCLE TIGHTNESS 63 0.0039
222 DYSARTHRIA 146 0.0039
223 PRODUCT PACKAGING DIFFICULT TO OPEN 10 0.0038
224 MENTAL STATUS CHANGES 106 0.0038
225 HYPERTONIC BLADDER 11 0.0038
226 SENSORY DISTURBANCE 61 0.0038
227 ATAXIA 45 0.0038
228 CERVICAL VERTEBRAL FRACTURE 13 0.0038
229 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
230 PRODUCT CLEANING INADEQUATE 10 0.0037
231 URINE ABNORMALITY 17 0.0037
232 TRIGEMINAL NEURALGIA 15 0.0037
233 THERAPEUTIC PRODUCT EFFECT DELAYED 17 0.0037
234 URINARY TRACT INFECTION 632 0.0037
235 FACIAL PARESIS 13 0.0037
236 HYPERTONIA 21 0.0037
237 COMMUNICATION DISORDER 14 0.0037
238 SOMNAMBULISM 24 0.0037
239 HIP FRACTURE 117 0.0036
240 HYPOPHAGIA 93 0.0036
241 BLOOD IMMUNOGLOBULIN G DECREASED 9 0.0036
242 DEVICE PLACEMENT ISSUE 13 0.0036
243 PSYCHOMOTOR HYPERACTIVITY 60 0.0036
244 INITIAL INSOMNIA 37 0.0036
245 SALIVARY HYPERSECRETION 36 0.0036
246 POOR QUALITY SLEEP 76 0.0035
247 URINARY INCONTINENCE 103 0.0035
248 JAW DISORDER 19 0.0035
249 GENERAL SYMPTOM 26 0.0035
250 SCREAMING 22 0.0035
251 PARTIAL SEIZURES 18 0.0034
252 DISORIENTATION 136 0.0034
253 DEVICE DISLOCATION 148 0.0034
254 CLAVICLE FRACTURE 13 0.0034
255 MUSCULOSKELETAL STIFFNESS 297 0.0034
256 SENSORY LOSS 27 0.0034
257 AGGRESSION 166 0.0033
258 DRUG EFFECT DELAYED 15 0.0033
259 AGITATION 242 0.0033
260 TENSION 20 0.0033
261 THERAPY CESSATION 168 0.0033
262 COORDINATION ABNORMAL 45 0.0032
263 EYE MOVEMENT DISORDER 22 0.0032
264 NEUROTOXICITY 56 0.0032
265 MICTURITION DISORDER 11 0.0032
266 SOMNOLENCE 637 0.0032
267 TOXIC ENCEPHALOPATHY 16 0.0032
268 HYPERREFLEXIA 11 0.0032
269 DYSPHAGIA 299 0.0031
270 SPINAL STENOSIS 13 0.0031
271 APHASIA 95 0.0031
272 THROMBOPHLEBITIS 11 0.0031
273 VITAMIN B12 DECREASED 9 0.0031
274 TIC 17 0.0031
275 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149 0.0031
276 PRESCRIBED OVERDOSE 60 0.0031
277 SLEEP DISORDER 217 0.0031
278 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
279 NERVE COMPRESSION 28 0.0030
280 MUSCULAR WEAKNESS 344 0.0030
281 DIPLOPIA 78 0.0030
282 DEVICE PHYSICAL PROPERTY ISSUE 23 0.0030
283 HYPERAMMONAEMIA 15 0.0030
284 HYPOMANIA 11 0.0030
285 ENCEPHALOPATHY 73 0.0030
286 ABNORMAL BEHAVIOUR 117 0.0030
287 MALNUTRITION 33 0.0029
288 LYMPHOCYTE COUNT DECREASED 52 0.0029
289 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
290 TRISMUS 15 0.0029
291 UNRESPONSIVE TO STIMULI 74 0.0029
292 SEDATION 75 0.0029
293 DEPRESSED MOOD 151 0.0029
294 URINARY RETENTION 95 0.0028
295 NYSTAGMUS 15 0.0028
296 DEVICE ISSUE 253 0.0028
297 FLUID INTAKE REDUCED 14 0.0028
298 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0028
299 BRUXISM 15 0.0028
300 RESTLESS LEGS SYNDROME 50 0.0027
301 SCOLIOSIS 17 0.0027
302 FOOD INTOLERANCE 10 0.0027
303 FORMICATION 19 0.0027
304 TEMPERATURE INTOLERANCE 28 0.0027
305 FEEDING DISORDER 55 0.0027
306 MEMORY IMPAIRMENT 372 0.0027
307 INFUSION SITE SWELLING 17 0.0027
308 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
309 LYMPHOPENIA 38 0.0027
310 SUBDURAL HAEMATOMA 38 0.0027
311 SLUGGISHNESS 27 0.0026
312 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 188 0.0026
313 BLOOD THYROID STIMULATING HORMONE DECREASED 12 0.0026
314 OPTIC NEURITIS 24 0.0026
315 CONSTIPATION 570 0.0026
316 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
317 FRUSTRATION TOLERANCE DECREASED 21 0.0026
318 INTERVERTEBRAL DISC DISORDER 11 0.0026
319 MUSCULOSKELETAL DISORDER 49 0.0026
320 RESTLESSNESS 94 0.0026
321 PELVIC FRACTURE 20 0.0026
322 TEARFULNESS 11 0.0026
323 PETIT MAL EPILEPSY 13 0.0025
324 BLOOD PRESSURE FLUCTUATION 61 0.0025
325 CHOKING SENSATION 14 0.0025
326 COLITIS MICROSCOPIC 12 0.0025
327 APPENDICECTOMY 9 0.0025
328 MANIA 41 0.0025
329 INGUINAL HERNIA 15 0.0025
330 VENTRICULAR ARRHYTHMIA 9 0.0025
331 CONCUSSION 19 0.0025
332 PRODUCT DOSE OMISSION 160 0.0024
333 LEUKOCYTOSIS 44 0.0024
334 HEMIPARESIS 41 0.0024
335 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
336 SEIZURE 278 0.0024
337 SKIN MASS 16 0.0024
338 SNORING 9 0.0024
339 FACE INJURY 9 0.0024
340 PERIPHERAL SWELLING 364 0.0024
341 MUSCLE FATIGUE 10 0.0024
342 BEDRIDDEN 31 0.0024
343 ENDOCARDITIS 12 0.0023
344 TARDIVE DYSKINESIA 65 0.0023
345 MUSCLE TWITCHING 53 0.0023
346 SPINAL OPERATION 28 0.0023
347 SOCIAL AVOIDANT BEHAVIOUR 13 0.0022
348 TERMINAL STATE 15 0.0022
349 BLEPHAROSPASM 14 0.0022
350 HYPOVOLAEMIA 13 0.0022
351 EMBEDDED DEVICE 22 0.0022
352 URINARY TRACT DISORDER 10 0.0022
353 HOMICIDAL IDEATION 9 0.0022
354 DISTURBANCE IN ATTENTION 119 0.0022
355 CYSTITIS 70 0.0022
356 GOITRE 9 0.0022
357 LIMB DISCOMFORT 68 0.0022
358 DEMYELINATION 9 0.0022
359 INSOMNIA 579 0.0022
360 PSYCHIATRIC SYMPTOM 16 0.0022
361 CONDITION AGGRAVATED 658 0.0022
362 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
363 THERAPEUTIC RESPONSE UNEXPECTED 96 0.0021
364 NEURALGIA 52 0.0021
365 UNEVALUABLE EVENT 161 0.0021
366 HYPERPYREXIA 9 0.0021
367 PRODUCT DISPENSING ISSUE 9 0.0021
368 BOWEL MOVEMENT IRREGULARITY 16 0.0021
369 SUBCUTANEOUS ABSCESS 10 0.0021
370 FOOT DEFORMITY 23 0.0021
371 GASTROINTESTINAL MOTILITY DISORDER 11 0.0021
372 VITAMIN D DEFICIENCY 20 0.0020
373 SPINAL OSTEOARTHRITIS 18 0.0020
374 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
375 THINKING ABNORMAL 38 0.0020
376 AFFECTIVE DISORDER 16 0.0020
377 LETHARGY 117 0.0020
378 HIP SURGERY 11 0.0020
379 PULMONARY THROMBOSIS 22 0.0020
380 INFUSION SITE PAIN 26 0.0020
381 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 10 0.0020
382 WRIST FRACTURE 24 0.0020
383 CONTUSION 192 0.0020
384 FEELING JITTERY 38 0.0020
385 BRADYPHRENIA 13 0.0020
386 JOINT DISLOCATION 21 0.0020
387 TROPONIN INCREASED 15 0.0020
388 MACULAR OEDEMA 11 0.0020
389 BLOOD PRESSURE ABNORMAL 39 0.0020
390 DRUG EFFECT LESS THAN EXPECTED 29 0.0020
391 NEUTROPHIL COUNT INCREASED 20 0.0020
392 DEPRESSION 444 0.0019
393 NEPHROGENIC ANAEMIA 9 0.0019
394 BREAST MASS 13 0.0019
395 DIZZINESS 962 0.0019
396 FAILURE TO THRIVE 10 0.0019
397 VENTRICULAR EXTRASYSTOLES 20 0.0019
398 POLYNEUROPATHY 23 0.0019
399 UPPER LIMB FRACTURE 38 0.0019
400 MENTAL IMPAIRMENT 46 0.0019
401 GASTROINTESTINAL INFECTION 17 0.0019
402 DRUG INTERACTION 300 0.0019
403 FACIAL PARALYSIS 16 0.0019
404 JOINT INJURY 40 0.0019
405 DEVICE BREAKAGE 76 0.0019
406 DRY THROAT 19 0.0019
407 FOOD POISONING 10 0.0019
408 WITHDRAWAL SYNDROME 78 0.0019
409 CARDIAC FLUTTER 12 0.0019
410 EUPHORIC MOOD 19 0.0019
411 DYSPHONIA 108 0.0018
412 HAND FRACTURE 13 0.0018
413 POLYURIA 15 0.0018
414 SMALL INTESTINAL OBSTRUCTION 22 0.0018
415 MAJOR DEPRESSION 13 0.0018
416 POLLAKIURIA 74 0.0018
417 GENERAL PHYSICAL HEALTH DETERIORATION 205 0.0018
418 ACUTE RESPIRATORY FAILURE 34 0.0018
419 ASTHENIA 663 0.0018
420 HIP ARTHROPLASTY 27 0.0018
421 VITAMIN D DECREASED 15 0.0018
422 HYPOAESTHESIA 260 0.0017
423 LOSS OF CONSCIOUSNESS 221 0.0017
424 AMNESIA 112 0.0017
425 URINE ODOUR ABNORMAL 10 0.0017
426 ABASIA 42 0.0017
427 ENERGY INCREASED 10 0.0017
428 INTERVERTEBRAL DISC PROTRUSION 37 0.0017
429 APHTHOUS ULCER 13 0.0017
430 VISUAL FIELD DEFECT 12 0.0017
431 NEPHROLITHIASIS 76 0.0017
432 DEHYDRATION 221 0.0017
433 FEELING ABNORMAL 397 0.0017
434 DEVICE LEAKAGE 71 0.0016
435 INJECTION SITE NODULE 18 0.0016
436 POSTOPERATIVE WOUND INFECTION 11 0.0016
437 SEXUAL DYSFUNCTION 19 0.0016
438 LIMB INJURY 44 0.0016
439 ARTHROPOD BITE 12 0.0016
440 MUSCLE STRAIN 14 0.0016
441 LIGAMENT SPRAIN 16 0.0016
442 TACHYPNOEA 22 0.0016
443 FEELING COLD 45 0.0016
444 MOOD ALTERED 44 0.0016
445 AKATHISIA 22 0.0016
446 PRODUCT DOSE OMISSION ISSUE 471 0.0016
447 ANXIETY 454 0.0016
448 GROIN PAIN 14 0.0016
449 GRIP STRENGTH DECREASED 14 0.0016
450 HICCUPS 13 0.0016
451 HEAD DISCOMFORT 28 0.0016
452 BLOOD PRESSURE DECREASED 105 0.0016
453 VISUAL IMPAIRMENT 195 0.0016
454 HYPERHIDROSIS 202 0.0016
455 THERAPY NON-RESPONDER 70 0.0016
456 UNINTENTIONAL MEDICAL DEVICE REMOVAL 18 0.0016
457 DIVERTICULUM 11 0.0015
458 ADVERSE DRUG REACTION 139 0.0015
459 OEDEMA PERIPHERAL 188 0.0015
460 PANIC ATTACK 56 0.0015
461 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
462 NERVOUSNESS 80 0.0015
463 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
464 PRESYNCOPE 37 0.0015
465 BLOOD LACTIC ACID INCREASED 8 0.0015
466 THERAPEUTIC PRODUCT EFFECT DECREASED 68 0.0015
467 GRAND MAL CONVULSION 14 0.0015
468 NASAL DISCOMFORT 12 0.0015
469 RHABDOMYOLYSIS 63 0.0015
470 PERSONALITY CHANGE 14 0.0015
471 TREATMENT NONCOMPLIANCE 82 0.0015
472 MENINGITIS 10 0.0015
473 MUSCLE SPASMS 274 0.0015
474 LACERATION 14 0.0015
475 FEELING DRUNK 11 0.0015
476 WEIGHT DECREASED 411 0.0015
477 VISION BLURRED 201 0.0015
478 UNDERDOSE 106 0.0015
479 SPINAL COMPRESSION FRACTURE 12 0.0014
480 SPINAL PAIN 17 0.0014
481 COMPLICATION ASSOCIATED WITH DEVICE 21 0.0014
482 SECRETION DISCHARGE 18 0.0014
483 FATIGUE 1118 0.0014
484 DEFAECATION URGENCY 10 0.0014
485 OCULAR DISCOMFORT 16 0.0014
486 BLOOD URINE PRESENT 27 0.0014
487 SCRATCH 15 0.0014
488 CELLULITIS 71 0.0014
489 SINUS TACHYCARDIA 20 0.0014
490 MYDRIASIS 18 0.0014
491 GLAUCOMA 27 0.0014
492 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
493 PARALYSIS 20 0.0014
494 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
495 TONGUE DISORDER 10 0.0014
496 COUGH 387 0.0014
497 POLYP 9 0.0014
498 BODY TEMPERATURE INCREASED 28 0.0014
499 APATHY 20 0.0014
500 WOUND INFECTION 15 0.0014
501 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 75 0.0014
502 DYSURIA 50 0.0014
503 ADVERSE REACTION 18 0.0014
504 COVID-19 PNEUMONIA 16 0.0014
505 SPINAL FRACTURE 27 0.0013
506 HYPOTENSION 269 0.0013
507 CEREBRAL HAEMORRHAGE 48 0.0013
508 GASTROENTERITIS VIRAL 24 0.0013
509 SKIN DISCOLOURATION 61 0.0013
510 VITREOUS FLOATERS 13 0.0013
511 THERAPY CHANGE 13 0.0013
512 DRUG EFFECT INCOMPLETE 48 0.0013
513 KNEE OPERATION 13 0.0013
514 SCIATICA 21 0.0013
515 CHOLECYSTECTOMY 15 0.0013
516 ANOSMIA 19 0.0013
517 PERIPHERAL COLDNESS 18 0.0013
518 RESPIRATION ABNORMAL 9 0.0013
519 TRANSIENT ISCHAEMIC ATTACK 44 0.0013
520 ENCEPHALITIS 9 0.0013
521 LARGE INTESTINE POLYP 9 0.0013
522 PARAESTHESIA 204 0.0013
523 BRAIN INJURY 13 0.0013
524 PRODUCT DISTRIBUTION ISSUE 12 0.0013
525 ANKLE FRACTURE 20 0.0013
526 EXTRAPYRAMIDAL DISORDER 32 0.0013
527 SARS-COV-2 TEST POSITIVE 17 0.0013
528 MENTAL DISORDER 56 0.0013
529 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
530 CHROMATURIA 29 0.0013
531 THERAPY PARTIAL RESPONDER 20 0.0013
532 BRAIN FOG 20 0.0013
533 PHOTOPHOBIA 24 0.0013
534 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
535 KIDNEY INFECTION 25 0.0013
536 BLOOD SODIUM DECREASED 24 0.0013
537 STAPHYLOCOCCAL INFECTION 42 0.0013
538 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
539 OSTEOMYELITIS 23 0.0013
540 RESPIRATORY DISTRESS 35 0.0013
541 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
542 HAEMATOCRIT DECREASED 25 0.0013
543 HYPERLIPIDAEMIA 15 0.0013
544 COLD SWEAT 22 0.0012
545 INTESTINAL OBSTRUCTION 47 0.0012
546 FLUSHING 126 0.0012
547 PRODUCT PHYSICAL ISSUE 25 0.0012
548 FAECES SOFT 9 0.0012
549 UTERINE LEIOMYOMA 9 0.0012
550 POST PROCEDURAL INFECTION 10 0.0012
551 FEELING HOT 75 0.0012
552 ORAL DISCOMFORT 17 0.0012
553 SENSITIVE SKIN 9 0.0012
554 SYNCOPE 122 0.0012
555 NECK PAIN 68 0.0012
556 FOOT FRACTURE 23 0.0012
557 THROAT IRRITATION 54 0.0012
558 ILL-DEFINED DISORDER 73 0.0012
559 BACK PAIN 279 0.0012
560 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
561 LOWER LIMB FRACTURE 23 0.0012
562 HEART RATE DECREASED 42 0.0012
563 BIPOLAR DISORDER 13 0.0012
564 CATARACT 71 0.0012
565 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
566 CRYING 43 0.0012
567 TOOTH FRACTURE 13 0.0012
568 ABNORMAL LOSS OF WEIGHT 8 0.0012
569 TACHYCARDIA 104 0.0012
570 SQUAMOUS CELL CARCINOMA 11 0.0012
571 FEMUR FRACTURE 36 0.0012
572 LOCALISED INFECTION 28 0.0012
573 COVID-19 203 0.0012
574 SLEEP APNOEA SYNDROME 22 0.0012
575 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
576 STATUS EPILEPTICUS 13 0.0011
577 HEART RATE IRREGULAR 26 0.0011
578 BRADYCARDIA 61 0.0011
579 AFFECT LABILITY 11 0.0011
580 HAEMORRHAGE INTRACRANIAL 17 0.0011
581 HOSPITALISATION 174 0.0011
582 VERTIGO 69 0.0011
583 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
584 HYPERTENSION 239 0.0011
585 DECREASED IMMUNE RESPONSIVENESS 11 0.0011
586 THIRST 20 0.0011
587 HYPONATRAEMIA 63 0.0011
588 RASH MACULAR 39 0.0011
589 IRRITABILITY 67 0.0011
590 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
591 HYPOCALCAEMIA 21 0.0011
592 DEVICE RELATED INFECTION 17 0.0011
593 MUSCULOSKELETAL DISCOMFORT 19 0.0011
594 HYPERAESTHESIA 9 0.0011
595 POST PROCEDURAL COMPLICATION 21 0.0011
596 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
597 ADVERSE EVENT 100 0.0011
598 SUICIDAL IDEATION 99 0.0011
599 EOSINOPHIL COUNT INCREASED 9 0.0011
600 INJECTION SITE INDURATION 14 0.0011
601 FEAR 29 0.0011
602 PNEUMOTHORAX 17 0.0011
603 SCHIZOPHRENIA 13 0.0011
604 SEPSIS 119 0.0011
605 PALLOR 29 0.0011
606 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
607 PNEUMONIA 343 0.0011
608 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
609 PRODUCT DISPENSING ERROR 23 0.0011
610 PRODUCT PRESCRIBING ISSUE 23 0.0011
611 IMPAIRED DRIVING ABILITY 12 0.0011
612 INTERNAL HAEMORRHAGE 12 0.0010
613 CYST 13 0.0010
614 KNEE ARTHROPLASTY 22 0.0010
615 DEVICE DIFFICULT TO USE 69 0.0010
616 DEATH 898 0.0010
617 HAEMATOMA 27 0.0010
618 HYSTERECTOMY 9 0.0010
619 PYELONEPHRITIS 9 0.0010
620 MALAISE 455 0.0010
621 CHOLELITHIASIS 34 0.0010
622 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
623 DECREASED APPETITE 240 0.0010
624 CONVULSION 59 0.0010
625 BLOOD POTASSIUM DECREASED 31 0.0010
626 BODY HEIGHT DECREASED 11 0.0010
627 RESPIRATORY FAILURE 74 0.0010
628 OSTEOARTHRITIS 43 0.0010
629 EPILEPSY 31 0.0010
630 TOXICITY TO VARIOUS AGENTS 171 0.0010
631 ROTATOR CUFF SYNDROME 13 0.0010
632 BACK INJURY 11 0.0010
633 FACIAL PAIN 9 0.0010
634 HIATUS HERNIA 13 0.0010
635 WOUND 28 0.0010
636 HYPOTONIA 10 0.0010
637 DRY EYE 50 0.0010
638 BLOOD TEST ABNORMAL 14 0.0010
639 PRODUCT ADMINISTRATION ERROR 20 0.0010
640 BLOOD PRESSURE INCREASED 151 0.0010
641 EATING DISORDER 21 0.0010
642 HERNIA 19 0.0010
643 DRUG INEFFECTIVE 1295 0.0010
644 TOOTH ABSCESS 10 0.0010
645 PAIN IN EXTREMITY 289 0.0010
646 SKIN INFECTION 11 0.0010
647 BRAIN NEOPLASM 9 0.0010
648 RESPIRATORY ARREST 27 0.0010
649 IMPAIRED QUALITY OF LIFE 14 0.0010
650 SURGERY 57 0.0010
651 MALIGNANT MELANOMA 13 0.0010
652 DRUG LEVEL INCREASED 16 0.0010
653 SINUS CONGESTION 13 0.0010
654 BASAL CELL CARCINOMA 15 0.0010
655 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
656 PULMONARY HYPERTENSION 20 0.0010
657 CONTRAINDICATED PRODUCT ADMINISTERED 29 0.0010
658 HOT FLUSH 72 0.0010
659 POISONING DELIBERATE 9 0.0009
660 MUSCLE ATROPHY 12 0.0009
661 ANGER 32 0.0009
662 EMOTIONAL DISORDER 29 0.0009
663 EXTRA DOSE ADMINISTERED 38 0.0009
664 DRUG WITHDRAWAL SYNDROME 82 0.0009
665 BLINDNESS 38 0.0009
666 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 168 0.0009
667 HYPOAESTHESIA ORAL 14 0.0009
668 RENAL IMPAIRMENT 78 0.0009
669 ACUTE KIDNEY INJURY 141 0.0009
670 DEVICE USE ERROR 32 0.0009
671 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 43 0.0009
672 CARDIAC ARREST 76 0.0009
673 SEASONAL ALLERGY 13 0.0009
674 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 65 0.0009
675 GASTRITIS 24 0.0009
676 MIGRAINE 87 0.0009
677 BACTERIAL INFECTION 17 0.0009
678 DRUG EFFECT DECREASED 49 0.0009
679 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
680 HEART RATE INCREASED 90 0.0009
681 MUSCULOSKELETAL CHEST PAIN 14 0.0009
682 EYE PAIN 51 0.0009
683 INFLUENZA LIKE ILLNESS 74 0.0009
684 INFECTION 129 0.0009
685 DRUG INTOLERANCE 86 0.0009
686 INFLUENZA 98 0.0009
687 SKIN HAEMORRHAGE 13 0.0009
688 INTENTIONAL DOSE OMISSION 25 0.0009
689 NAUSEA 694 0.0009
690 IMMUNODEFICIENCY 13 0.0009
691 BURNING SENSATION 61 0.0009
692 SKIN DISORDER 29 0.0009
693 NIGHT SWEATS 28 0.0009
694 NERVOUS SYSTEM DISORDER 27 0.0009
695 BACK DISORDER 14 0.0009
696 WEIGHT FLUCTUATION 9 0.0009
697 MASS 12 0.0009
698 SWELLING 80 0.0009
699 THERAPY INTERRUPTED 61 0.0009
700 C-REACTIVE PROTEIN INCREASED 31 0.0009
701 SUDDEN DEATH 9 0.0008
702 INCORRECT DOSE ADMINISTERED BY DEVICE 22 0.0008
703 INCREASED APPETITE 16 0.0008
704 SKIN CANCER 18 0.0008
705 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
706 ARRHYTHMIA 39 0.0008
707 GASTROENTERITIS 12 0.0008
708 NO THERAPEUTIC RESPONSE 10 0.0008
709 ORAL HERPES 16 0.0008
710 COMA 39 0.0008
711 SCAR 14 0.0008
712 PRODUCTIVE COUGH 39 0.0008
713 EXPIRED PRODUCT ADMINISTERED 27 0.0008
714 VIRAL INFECTION 27 0.0008
715 INTENTIONAL PRODUCT MISUSE 71 0.0008
716 TENDON RUPTURE 10 0.0008
717 SINUS DISORDER 16 0.0008
718 IMPAIRED GASTRIC EMPTYING 11 0.0008
719 DISCOMFORT 49 0.0008
720 BLOOD POTASSIUM INCREASED 13 0.0008
721 HYPOXIA 28 0.0008
722 DERMATITIS ALLERGIC 10 0.0008
723 GASTROINTESTINAL DISORDER 71 0.0008
724 COMPLETED SUICIDE 66 0.0008
725 ATRIAL FIBRILLATION 77 0.0008
726 PRODUCT AVAILABILITY ISSUE 18 0.0008
727 FLUID RETENTION 40 0.0008
728 HEADACHE 493 0.0008
729 BRONCHITIS 58 0.0008
730 ABDOMINAL DISCOMFORT 131 0.0008
731 BLINDNESS UNILATERAL 11 0.0008
732 NEUROPATHY PERIPHERAL 74 0.0008
733 DRUG DOSE OMISSION 128 0.0008
734 RHINORRHOEA 50 0.0008
735 NASOPHARYNGITIS 142 0.0008
736 NODULE 10 0.0008
737 CARDIO-RESPIRATORY ARREST 32 0.0008
738 CIRCULATORY COLLAPSE 13 0.0008
739 JOINT STIFFNESS 20 0.0008
740 EYE DISORDER 25 0.0008
741 WEIGHT INCREASED 170 0.0008
742 ULCER 12 0.0008
743 ACCIDENT 9 0.0008
744 ABSCESS 12 0.0008
745 HYPOTHYROIDISM 24 0.0008
746 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
747 RETCHING 16 0.0007
748 DEVICE DEFECTIVE 13 0.0007
749 PAIN 459 0.0007
750 ACUTE MYOCARDIAL INFARCTION 22 0.0007
751 ERECTILE DYSFUNCTION 19 0.0007
752 BLOOD CREATININE INCREASED 48 0.0007
753 OROPHARYNGEAL PAIN 68 0.0007
754 DYSPEPSIA 72 0.0007
755 CORONARY ARTERY OCCLUSION 10 0.0007
756 GALLBLADDER DISORDER 13 0.0007
757 ABDOMINAL DISTENSION 76 0.0007
758 INJECTION SITE REACTION 50 0.0007
759 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
760 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
761 TOOTH EXTRACTION 9 0.0007
762 FLATULENCE 41 0.0007
763 SINUSITIS 74 0.0007
764 MOOD SWINGS 23 0.0007
765 INSURANCE ISSUE 11 0.0007
766 DISEASE PROGRESSION 85 0.0007
767 PRODUCT USE ISSUE 135 0.0007
768 BLOOD UREA INCREASED 12 0.0007
769 APHONIA 10 0.0007
770 CARPAL TUNNEL SYNDROME 10 0.0007
771 PRODUCT PRESCRIBING ERROR 17 0.0007
772 THYROID DISORDER 11 0.0007
773 HERPES ZOSTER 41 0.0007
774 JOINT SWELLING 86 0.0007
775 BLOOD CHOLESTEROL INCREASED 33 0.0007
776 INJECTION SITE IRRITATION 9 0.0007
777 INJECTION SITE MASS 26 0.0007
778 THROAT TIGHTNESS 19 0.0007
779 HEPATIC STEATOSIS 13 0.0007
780 NASAL CONGESTION 41 0.0007
781 PULMONARY EMBOLISM 66 0.0007
782 DEVICE DELIVERY SYSTEM ISSUE 19 0.0007
783 PARAESTHESIA ORAL 10 0.0007
784 RENAL FAILURE 92 0.0007
785 RESPIRATORY TRACT INFECTION 18 0.0007
786 HYPERTHYROIDISM 10 0.0007
787 CEREBROVASCULAR ACCIDENT 117 0.0007
788 FUNGAL INFECTION 23 0.0007
789 DEAFNESS 18 0.0007
790 FRACTURE 13 0.0007
791 RENAL DISORDER 32 0.0007
792 INTENTIONAL OVERDOSE 44 0.0007
793 PROCEDURAL PAIN 19 0.0007
794 IMMUNE SYSTEM DISORDER 9 0.0007
795 PULMONARY CONGESTION 9 0.0007
796 ALOPECIA 134 0.0007
797 EAR INFECTION 18 0.0007
798 CHILLS 79 0.0007
799 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
800 DYSPNOEA 381 0.0007
801 ROAD TRAFFIC ACCIDENT 28 0.0007
802 CHEST DISCOMFORT 68 0.0007
803 OEDEMA 36 0.0007
804 VISUAL ACUITY REDUCED 22 0.0007
805 CARDIAC FAILURE 53 0.0007
806 HYPOGLYCAEMIA 32 0.0007
807 END STAGE RENAL DISEASE 12 0.0007
808 PALPITATIONS 77 0.0007
809 ACCIDENTAL OVERDOSE 24 0.0007
810 PYREXIA 227 0.0007
811 VOMITING 308 0.0007
812 TINNITUS 30 0.0007
813 HYPOACUSIS 28 0.0006
814 RASH PRURITIC 35 0.0006
815 HEPATIC ENZYME INCREASED 44 0.0006
816 EYE SWELLING 24 0.0006
817 PRODUCT USE IN UNAPPROVED INDICATION 158 0.0006
818 OBESITY 10 0.0006
819 INJECTION SITE BRUISING 50 0.0006
820 METABOLIC ACIDOSIS 20 0.0006
821 OFF LABEL USE 546 0.0006
822 OXYGEN SATURATION DECREASED 35 0.0006
823 SEPTIC SHOCK 27 0.0006
824 MUSCULOSKELETAL PAIN 32 0.0006
825 DYSPNOEA EXERTIONAL 23 0.0006
826 SUICIDE ATTEMPT 37 0.0006
827 ARTHRITIS 48 0.0006
828 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
829 IMPAIRED WORK ABILITY 13 0.0006
830 VENTRICULAR TACHYCARDIA 10 0.0006
831 PHOTOSENSITIVITY REACTION 10 0.0006
832 CHRONIC KIDNEY DISEASE 46 0.0006
833 CHEST PAIN 112 0.0006
834 ABDOMINAL PAIN UPPER 124 0.0006
835 AGEUSIA 15 0.0006
836 LIP SWELLING 20 0.0006
837 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
838 LEUKOPENIA 30 0.0006
839 SWELLING FACE 39 0.0006
840 THERAPEUTIC RESPONSE DECREASED 36 0.0006
841 CARDIAC DISORDER 55 0.0006
842 DEEP VEIN THROMBOSIS 38 0.0006
843 TOOTH DISORDER 13 0.0006
844 SKIN LESION 16 0.0006
845 LYMPHOMA 9 0.0006
846 PULMONARY OEDEMA 26 0.0006
847 IMPAIRED HEALING 19 0.0006
848 LABORATORY TEST ABNORMAL 17 0.0006
849 FIBROMYALGIA 14 0.0006
850 LOCAL SWELLING 10 0.0006
851 ILLNESS 59 0.0006
852 CYANOSIS 9 0.0006
853 THROMBOSIS 46 0.0006
854 PRODUCT USE COMPLAINT 9 0.0006
855 INJURY 40 0.0006
856 EAR PAIN 11 0.0006
857 HAEMORRHOIDS 11 0.0006
858 WHITE BLOOD CELL COUNT DECREASED 61 0.0006
859 INFLAMMATION 29 0.0006
860 ERYTHEMA 115 0.0006
861 DISABILITY 11 0.0006
862 ABDOMINAL PAIN LOWER 14 0.0006
863 TOOTHACHE 10 0.0006
864 LUNG DISORDER 27 0.0006
865 INTENTIONAL SELF-INJURY 11 0.0005
866 SWOLLEN TONGUE 17 0.0005
867 DIVERTICULITIS 15 0.0005
868 ARTHROPATHY 30 0.0005
869 CONJUNCTIVITIS 10 0.0005
870 RESPIRATORY DISORDER 16 0.0005
871 CANDIDA INFECTION 9 0.0005
872 LACRIMATION INCREASED 16 0.0005
873 DERMATITIS 11 0.0005
874 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
875 HYPERGLYCAEMIA 19 0.0005
876 PULMONARY FIBROSIS 10 0.0005
877 HYPOKALAEMIA 24 0.0005
878 OVERDOSE 112 0.0005
879 RENAL FAILURE ACUTE 22 0.0005
880 BLISTER 29 0.0005
881 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 104 0.0005
882 CARDIOVASCULAR DISORDER 13 0.0005
883 INCORRECT DOSE ADMINISTERED 115 0.0005
884 ARTHRALGIA 209 0.0005
885 HAEMOPTYSIS 14 0.0005
886 COLITIS 19 0.0005
887 INJECTION SITE ERYTHEMA 62 0.0005
888 PRURITUS 191 0.0005
889 APPLICATION SITE ERYTHEMA 13 0.0005
890 TASTE DISORDER 10 0.0005
891 DIABETES MELLITUS 37 0.0005
892 HYPERKALAEMIA 17 0.0005
893 MYALGIA 82 0.0005
894 ABDOMINAL PAIN 112 0.0005
895 HYPERSENSITIVITY 89 0.0005
896 GASTRIC DISORDER 16 0.0005
897 LIVER FUNCTION TEST INCREASED 10 0.0005
898 SKIN ULCER 12 0.0005
899 PRURITUS GENERALISED 10 0.0005
900 FAECES DISCOLOURED 10 0.0005
901 GLOSSODYNIA 10 0.0004
902 ASTHMA 50 0.0004
903 HAEMOGLOBIN DECREASED 45 0.0004
904 HAEMATURIA 15 0.0004
905 BLOOD GLUCOSE DECREASED 21 0.0004
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
907 CARDIAC FAILURE CONGESTIVE 35 0.0004
908 SHOCK 10 0.0004
909 HAEMATEMESIS 11 0.0004
910 INJECTION SITE PRURITUS 29 0.0004
911 DRUG ABUSE 36 0.0004
912 RASH 186 0.0004
913 LYMPHADENOPATHY 15 0.0004
914 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
915 ANAEMIA 80 0.0004
916 ANHEDONIA 11 0.0004
917 DIARRHOEA 269 0.0004
918 LIVER FUNCTION TEST ABNORMAL 12 0.0004
919 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
920 PAIN OF SKIN 11 0.0004
921 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
922 OCULAR HYPERAEMIA 19 0.0004
923 PRODUCT SUBSTITUTION ISSUE 23 0.0004
924 DISEASE RECURRENCE 19 0.0004
925 HEPATIC FAILURE 12 0.0004
926 CORONARY ARTERY DISEASE 12 0.0004
927 NEUTROPHIL COUNT DECREASED 16 0.0004
928 HAEMORRHAGE 41 0.0004
929 OSTEOPOROSIS 16 0.0004
930 URTICARIA 65 0.0004
931 EYE IRRITATION 22 0.0004
932 MYOCARDIAL INFARCTION 66 0.0004
933 DYSGEUSIA 28 0.0004
934 HEPATIC FUNCTION ABNORMAL 14 0.0004
935 EPISTAXIS 28 0.0004
936 LIVER INJURY 9 0.0004
937 BREAST CANCER 34 0.0004
938 DRUG ADMINISTRATION ERROR 11 0.0004
939 TYPE 2 DIABETES MELLITUS 12 0.0004
940 RASH ERYTHEMATOUS 17 0.0004
941 PAIN IN JAW 10 0.0004
942 APPLICATION SITE PRURITUS 8 0.0004
943 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
944 RECTAL HAEMORRHAGE 15 0.0003
945 ANGINA PECTORIS 10 0.0003
946 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
947 THROMBOCYTOPENIA 38 0.0003
948 TREATMENT FAILURE 28 0.0003
949 EMOTIONAL DISTRESS 40 0.0003
950 PLEURAL EFFUSION 20 0.0003
951 INFUSION RELATED REACTION 21 0.0003
952 RED BLOOD CELL COUNT DECREASED 9 0.0003
953 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
954 SKIN EXFOLIATION 26 0.0003
955 HAEMATOCHEZIA 17 0.0003
956 PRODUCT ADHESION ISSUE 11 0.0003
957 MEDICATION ERROR 17 0.0003
958 OSTEONECROSIS 10 0.0003
959 WHEEZING 18 0.0003
960 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
961 INJECTION SITE SWELLING 22 0.0003
962 DEVICE MALFUNCTION 20 0.0003
963 PANCREATITIS 15 0.0003
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
965 BONE PAIN 15 0.0003
966 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
967 INJECTION SITE HAEMORRHAGE 20 0.0003
968 ABORTION SPONTANEOUS 10 0.0002
969 ECZEMA 13 0.0002
970 INJECTION SITE PAIN 75 0.0002
971 DRY SKIN 32 0.0002
972 PRODUCT QUALITY ISSUE 32 0.0002
973 STOMATITIS 14 0.0002
974 NO ADVERSE EVENT 41 0.0002
975 LIVER DISORDER 10 0.0002
976 PLATELET COUNT DECREASED 24 0.0002
977 SKIN BURNING SENSATION 16 0.0002
978 NEUTROPENIA 30 0.0002
979 VAGINAL HAEMORRHAGE 9 0.0002
980 BLOOD GLUCOSE INCREASED 35 0.0002
981 NEOPLASM MALIGNANT 12 0.0002
982 BLADDER CANCER 10 0.0002
983 PANCYTOPENIA 9 0.0002
984 ACNE 12 0.0002
985 DEVICE EXPULSION 10 0.0002
986 PROSTATE CANCER 12 0.0001
987 PRODUCT STORAGE ERROR 12 0.0001
988 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
989 RHEUMATOID ARTHRITIS 15 0.0001
990 PSORIASIS 15 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
992 DRUG DEPENDENCE 15 0.0001